To: | Alnylam Pharmaceuticals, Inc. (hiebert@samuelsTM.com) |
Subject: | U.S. Trademark Application Serial No. 88637585 - ONPATTRO - N/A |
Sent: | January 08, 2020 12:58:29 PM |
Sent As: | ecom121@uspto.gov |
Attachments: |
United States Patent and Trademark Office (USPTO)
Office Action (Official Letter) About Applicant’s Trademark Application
U.S. Application Serial No. 88637585
Mark: ONPATTRO
|
|
Correspondence Address: |
|
Applicant: Alnylam Pharmaceuticals, Inc.
|
|
Reference/Docket No. N/A
Correspondence Email Address: |
|
EXAMINER’S AMENDMENT
Issue date: January 08, 2020
USPTO database searched; no conflicting marks found. The trademark examining attorney searched the USPTO database of registered and pending marks and found no conflicting marks that would bar registration under Trademark Act Section 2(d). 15 U.S.C. §1052(d); TMEP §704.02.
Application has been amended as shown below. As agreed to by Timothy Hiebert on January 8, 2020, the examining attorney has amended the application as shown below. Please notify the examining attorney immediately of any objections. TMEP §707. Otherwise, no response is required. Id. In addition, applicant is advised that amendments to the goods are permitted only if they clarify or limit them; amendments that add to or broaden the scope of the goods are not permitted. 37 C.F.R. §2.71(a).
DESCRIPTION OF THE MARK AMENDED
The following description of the mark replaces the current description of record:
The mark consists of the word "ONPATTRO" shown in purple, and a stylized representation of the DNA molecule shown in green and light green, between the upper strands of which is a roughly triangular shape shown in light green. White appearing in the mark represents background or transparent areas only and is not claimed as a feature of the mark.
See 37 C.F.R. §§2.37, 2.72; TMEP §§808 et seq.
/Timothy J. Callery/
Timothy J. Callery
Examining Attorney
Law Office 121
(571) 270-1987
tim.callery@uspto.gov